Astra Zeneca Articles

Stock Commentary Europe

22 April 1999

Zeneca seeks injunction over generic propofol

21 April 1999

AstraZeneca rated outperform by MSDW

19 April 1999

Gene mapping consortium may rival genomics players

15 April 1999

Stock Commentary Europe

14 April 1999

UK drug stock's rebound sustainable, says Commerzbank

13 April 1999

Stock Commentary Europe

8 April 1999

AstraZeneca merger completed, leaps to third in pharmaceutical sales league

8 April 1999

US pharma firms winning marketing battle with 20 of global top 25 drugs by

7 April 1999

DuPont preparing to acquire Monsanto?

4 March 1999

Seretide launched in UK and shows promise in comparative trials

3 March 1999

AstraZeneca gets EU approval as Chiroscience prepares to reap the reward

2 March 1999

Zeneca shows confidence on Astra merger; reports good 1998 results

17 February 1999

Stock Commentary Europe

4 February 1999

Astra shareholders oppose Zeneca merger

27 January 1999

AstraZeneca offer document out, UK group's nine-month profits down

22 January 1999

AstraZeneca file for competition law approval

21 January 1999

Correction - pioglitazone

13 January 1999

The case for switching from Astra to Zeneca

8 January 1999

Arrival of the euro highlights fragmented European pharmaceutical market

6 January 1999

Novartis to stand alone for now, says chief exec

29 December 1998

AstraZeneca's Effect On Rest Of Pharma Sector

17 December 1998

Chirocaine Approved In First Market

16 December 1998

GW, SB Lining Up Offers For Zeneca?

15 December 1998

AstraZeneca Hoping To Increase Share In Japan

11 December 1998

Astra & Zeneca Join In Euro Merger Mania

10 December 1998

Astra & Zeneca Join In Euro Merger Mania

9 December 1998

GSK could announce 10,000 lay-offs

Jan Lundberg tells the Marketletter how AstraZeneca is turning around its pipeline